Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Mar 6 2016

Primary Sclerosing Cholangitis

Snap Shot
  •  A 28-year-old male with a past medical history significant for ulcerative colitis presents with a gradual worsening fatigue associated with jaundice.
Introduction
  • A chronic cholestatic syndrome characterized by
    • fibrosing inflammation in the intrahepatic and extrahepatic bile ducts
      • leading to narrowing and, eventually, obliteration of the bile ducts
      • leads to cirrhosis
  • The cause of primary sclerosing cholangitis (PSC) is unknown.
    • theoretic pathogens include toxins, infectious agents, and abnormalities in immune regulation.
  • PSC occurs most often in:
    • young men
    • commonly associated with inflammatory bowel disease (especially ulcerative colitis)
  • 7 to 10% of patients with PSC develop cholangiocarcinoma.
    • optimal timing of transplantation to prevent this complication is unknown
Presentation
  • Symptoms/Physical exam
    • the onset is usually insidious with
      • gradual, progressive fatigue
      • pruritus
      • jaundice
      • some present with hepatosplenomegaly or features of cirrhosis
    • the terminal phase is characterized by
      • decompensated cirrhosis
      • portal hypertension
      • ascites
      • liver failure
Evaluation
  • Labs 
    • elevated serum alkaline phosphatase
    • bilirubin elevation is variable
  • PSC is most readily diagnosed by direct cholangiography (preferably ERCP) which shows
    • multiple short strictures and saccular dilations 
    • involving intrahepatic and extrahepatic bile ducts
    • give the biliary tree an irregular beaded appearance
  • The diagnosis is also supported by liver biopsy which shows
    • bile duct proliferation
    • periductal fibrosis and inflammation
    • loss of bile ducts
  • PSC the mitochondrial antibody test is negative (unlike in primary biliary cirrhosis)
  • As the disease progresses, fibrosis extends from the portal regions and eventually leads to biliary cirrhosis.
Treatment
  • Endoscopic balloon dilation of strictures may relieve symptoms
  • Endoscopic stent (drain or tube) placement for major strictures may be a possibility
  • Liver transplantation prior to liver failure is a possibility in selected cases
Prognosis, Prevention, and Complications
  • Prognosis is poor
    • most persons survive just a few years after the symptoms develop
  • Liver failure,cholangiocarcinoma
Question
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options